Related content

Determination of HER2 Gene Amplification by Fluorescence In situ Hybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with Trastuzumab

By Dybdal Noël   Leiberman Grazyna   Anderson Steven   McCune Bryan   Bajamonde Alex   Cohen Robert   Mass Robert   Sanders Corsee   Press Michael  

Breast Cancer Research and Treatment, Vol. 93, Iss. 1, 2005-09 ,pp. : 3-11

Springer Publishing Company

Access to resources Recommend Favorite

Fluorescence in situ hybridization of chromosome 17 polysomy in breast cancer using thin tissue sections causes the loss of CEP17 and HER2 signals

By          

Oncology Reports, Vol. 32, Iss. 5, 2014-01 ,pp. : 1889-1896

Spandidos Publications

Access to resources Recommend Favorite

Genomic Large Rearrangement Screening of BRCA1 and BRCA2 Genes in High-Risk Turkish Breast/Ovarian Cancer Patients by Using Multiplex Ligation-Dependent Probe Amplification Assay

By Manguoğlu Esra   Güran Şefik   Yamaç Deniz   Şimşek Mehmet   Akdeniz Selime   Çolak Taner   Gülkesen Hakan   Lüleci Güven  

Cancer Investigation, Vol. 29, Iss. 1, 2011-01 ,pp. : 73-77

Informa Healthcare

Access to resources Recommend Favorite

Differential diagnosis of solitary fibrous tumors: A study of 454 soft tissue tumors indicating the diagnostic value of nuclear STAT6 relocation and ALDH1 expression combined with in situ proximity ligation assay

By              

International Journal of Oncology, Vol. 46, Iss. 6, 2015-01 ,pp. : 2595-2605

Spandidos Publications

Access to resources Recommend Favorite

Accurate breast cancer diagnosis through real-time PCR her2 gene quantification using immunohistochemically-identified biopsies

By      

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 295-298

Spandidos Publications

Access to resources Recommend Favorite